$4700
The global hemato oncology testing market is expected to grow from USD 2.01 billion in 2019 to USD 6.03 billion by 2027, at a CAGR of 14.8% during the forecast period 2020-2027.
Hemato oncology testing is used to prevent, treat and diagnose cancer and blood diseases. Haematology tests involves tests on blood-producing organs, blood proteins and blood. It is used to evaluate anaemia, haemophilia, infection, inflammation, leukaemia and blood-clotting disorders. Oncology testing is done in order to identify an existing disease, guide treatment decisions and predict future cancer. The global hemato oncology testing market is driven by an increased number of tumor and blood diseases. Also, established collaborations for developing new assays, growing awareness, increased prevalence of haematological cancer, and rise in the geriatric population are contributing to increasing demand for hemato oncology testing market.
This study delivers a comprehensive analysis of cancer types, product & service types, technologies and regions. The cancer type segment includes Hodgkin lymphoma, non-Hodgkin lymphoma, lymphoma, acute lymphocytic leukemia, acute myeloid leukemia and leukemia. Myeloid leukemia has the largest share of cancer type segment due to lack of early diagnosis of leukemia. Also, limited options available for treatment are causing the rise in myeloid leukemia. The product & service type segment includes assay kits and services. The services segment has the largest share of hemato oncology testing market due to prevalence of myeloma cancers, non-Hodgkin lymphoma and leukemia. The technology segment includes cytogenetics, IHC, NGS and PCR. PCR segment has the largest market share and is expected to grow higher due to the extensive use of advanced technology which is resulting in easy availability and ease of use of assay kits.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North-America has the largest share of hemato oncology testing market due to an increased research and development in this region. A rise in the prevalence of cancer and blood-related diseases are driving the market in North-America. Also, Technological advancements in hemato oncology testing market is driving the market in the region.
Some of the notable players in the global hemato oncology testing market are Abbott Laboratories, QIAGEN N.V., Illumina Inc., Invivoscribe Inc., Adaptive Biotechnologies, ARUP Laboratories Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Asuragen, Inc., ArcherDx, Inc. And MolecularMD. F. Hoffmann-La Roche Ltd. offers tests for the treatment of hemato-oncology cancers such as lymphoma, myeloma and leukemia. It has robust distribution channels, active presence across the globe and brand image. Abbott Laboratories is investing a tremendous amount of money in research and development and has introduced products such as Abbott RealTime IDH2 assay kits and Abbott RealTime IDH1 assay kits.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Hemato Oncology Testing Market Analysis And Forecast, By Cancer Type
Global Hemato Oncology Testing Market Analysis And Forecast, By Product & Service Type
Global Hemato Oncology Testing Market Analysis And Forecast, By Technology
Global Hemato Oncology Testing Market Analysis And Forecast, By Regional Analysis
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Cancer Type
4.3.2. Market Attractiveness Analysis By Product & Service Type
4.3.3. Market Attractiveness Analysis By Technology
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Global Hemato Oncology Testing Market Analysis and Forecast, By Cancer Type
6.1. Segment Overview
6.2. Hodgkin Lymphoma
6.3. Non-Hodgkin Lymphoma
6.4. Lymphoma
6.5. Acute Lymphocytic Leukemia
6.6. Acute Myeloid Leukemia
6.7. Leukemia
7. Global Hemato Oncology Testing Market Analysis and Forecast, By Product & Service Type
7.1. Segment Overview
7.2. Assay Kits
7.3. Services
8. Global Hemato Oncology Testing Market Analysis and Forecast, By Technology
8.1. Segment Overview
8.2. Cytogenetics
8.3. IHC
8.4. NGS
8.5. PCR
9. Global Hemato Oncology Testing Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Hemato Oncology Testing Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Hemato Oncology Testing Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. QIAGEN N.V.
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Illumina Inc.
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Invivoscribe Inc.
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Adaptive Biotechnologies
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. ARUP Laboratories Inc.
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. F. Hoffmann-La Roche Ltd.
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Bio-Rad Laboratories Inc.
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Thermo Fisher Scientific Inc.
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Asuragen, Inc.
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
List of Table
1. Global Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
2. Global Hodgkin Lymphoma In Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
3. Global Non-Hodgkin Lymphoma In Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
4. Global Lymphoma In Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
5. Global Acute Lymphocytic Leukemia Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
6. Global Acute Myeloid LeukemiaHemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
7. Global Leukemia Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
8. Global Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
9. Global Assay Kits, Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
10. Global Services, Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
11. Global Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
12. Global Cytogenetics, Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
13. Global IHC, Hemato Oncology Testing Market, By Region, 2017–2027 (USD Billion)
14. Global NGS, Hemato Oncology Testing Market, By Region, 2017–2027 (USD Billion)
15. Global PCR, Hemato Oncology Testing Market, By Region, 2017–2027 (USD Billion)
16. Global Hemato Oncology Testing Market, By Region, 2017–2027(USD Billion)
17. Global Hemato Oncology Testing Market, By North America, 2017–2027(USD Billion)
18. North America Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
19. North America Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
20. North America Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
21. U.S. Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
22. U.S. Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
23. U.S. Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
24. Canada Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
25. Canada Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
26. Canada Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
27. Mexico Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
28. Mexico Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
29. Mexico Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
30. Europe Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
31. Europe Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
32. Europe Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
33. Germany Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
34. Germany Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
35. Germany Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
36. France Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
37. France Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
38. France Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
39. U.K. Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
40. U.K. Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
41. U.K. Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
42. Italy Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
43. Italy Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
44. Italy Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
45. Spain Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
46. Spain Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
47. Spain Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
48. Asia Pacific Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
49. Asia Pacific Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
50. Asia Pacific Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
51. Japan Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
52. Japan Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
53. Japan Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
54. China Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
55. China Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
56. China Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
57. India Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
58. India Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
59. India Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
60. South America Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
61. South America Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
62. South America Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
63. Brazil Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
64. Brazil Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
65. Brazil Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
66. Middle East and Africa Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
67. Middle East and Africa Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
68. Middle East Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
69. UAE Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
70. UAE Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
71. UAE Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
72. South Africa Hemato Oncology Testing Market, By Cancer Type, 2017–2027(USD Billion)
73. South Africa Hemato Oncology Testing Market, By Product & Service Type, 2017–2027(USD Billion)
74. South Africa Hemato Oncology Testing Market, By Technology, 2017–2027(USD Billion)
List of Figures
1. Global Hemato Oncology Testing Market Segmentation
2. Hemato Oncology Testing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Hemato Oncology Testing Market Attractiveness Analysis By Cancer Type
9. Global Hemato Oncology Testing Market Attractiveness Analysis By Product & Service Type
10. Global Hemato Oncology Testing Market Attractiveness Analysis By Technology
11. Global Hemato Oncology Testing Market Attractiveness Analysis By Region
12. Global Hemato Oncology Testing Market: Dynamics
13. Global Hemato Oncology Testing Market Share By Cancer Type (2019 & 2027)
14. Global Hemato Oncology Testing Market Share By Product & Service Type (2019 & 2027)
15. Global Hemato Oncology Testing Market Share By Technology (2019 & 2027)
16. Global Hemato Oncology Testing Market Share by Regions (2019 & 2027)
17. Global Hemato Oncology Testing Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –
Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance
Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.
Dear Siddhartha, The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us. Thanks for all your help!
Hi Siddhartha-san, Many thanks for sending trade map with final report. Best regards,
Hello Sapna,
Thanks for the report. We've been going through it and see some good data on the market and players.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.
IND